Source: International Congress 2016 – The future of lung function is beginning now
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Maria Angeles Munoz (Madrid, Spain), Maria Angeles Munoz, Javier Jareño, Óscar Gómez, Sergio Utrilla, Francisco Villegas, Carlos Gutiérrez, Luis Callol. Volatile organic compounds in COPD: Is hexanal an inflammation biomarker?. Eur Respir J 2016; 48: Suppl. 60, 4412

Member's Comments

No comment yet.

Related content which might interest you: Breath volatile organic compound (VOC) COPD study at two DZL centers - Evaluation of site-specific VOC Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Breath volatile organic compounds and inflammatory markers in adult asthma patients: negative results from the ALLIANCE cohort Source: Eur Respir J, 57 (2) 2002127; 10.1183/13993003.02127-2020 Year: 2021 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Can exhaled volatile organic compounds predict asthma exacerbations in children? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Multiple detectable exhaled volatile organic compounds (vocs) may serve as potential inflammatory biomarkers in COPD Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Volatile organic compounds (VOCs) in COPD patients with exacerbation Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Volatile organic compounds (VOC) in exhaled breath of patients with COPD Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Breathprint of severe allergic asthma with SPME-GC-MS Analysis of exhaled air volatile organic compounds(Ege University translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Airway biomarkers Year: 2016 Measuring exhaled hydrogen sulphide (eH2S) levels in asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016